Skip to main content
. 2016 Apr 15;32(6):969–975. doi: 10.1093/ndt/gfw060

Table 1.

Baseline mean uMCP1 for tolvaptan and placebo treatment groups

Treatment N Mean (SD) (pg/mg) Meana (SD) (pg/mg) Median (pg/mg) IQR (pg/ mg) Min (pg/ mg) Max (pg/ mg)
Tolvaptan 869 493 (288) 429 (224) 425 290 76 2576
Placebo 438 500 (281) 434 (233) 430 296 67 1829

aThe means were obtained as an anti-logarithm of the mean of log-transformed uMCP1 and the SD was determined by the delta method. SD, standard deviation; IQR, interquartile range.